CRNX
NASDAQ · Pharmaceuticals
Crinetics Pharmaceuticals In
$84.95
+0.11 (+0.13%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+136.89%
YTD
+81.79%
Open$84.96
Previous Close$84.84
Day High$85.01
Day Low$84.92
52W High$85.01
52W Low$32.30
Volume—
Avg Volume3.02M
Market Cap9.01B
P/E Ratio—
EPS$-5.05
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$49.40
Above
SMA 200
$38.81
Above
RSI (14)
27.9
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
20 analysts
Price Target
-41.8% upside
Current
$84.95
$84.95
Target
$49.40
$49.40
$38.77
$49.40 avg
$74.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.68M | 7.38M | 1.14B |
| Net Income | -524,874,217 | -401,928,695 | 346.78M |
| Profit Margin | -6,046.2% | -5,743.9% | 30.3% |
| EBITDA | -578,526,564 | -467,625,487 | 475.78M |
| Free Cash Flow | — | — | 205.84M |
| Rev Growth | +17.5% | +17.5% | +24.5% |
| Debt/Equity | — | — | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |